Mannkind Corporation (MNKD) Stock Price

MNKDStock

$3.95−12.03%52W

Market Cap$1.27B

P/E210.05x

PEG Ratio4.39

Div yield—

Beta1.09

MNKD Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-40.63%

Price vs S&P 500 (4W)2.41%

PEG Ratio4.39

VGM Score42.37

P/E Ratio (Annual)210.05x

P/CF (Annual)67.46x

Book Value / Share (Quarterly)$0.23

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)51.78%

Cash Flow / Share (Quarterly)$-0.06

Price vs S&P 500 (YTD)-43.16%

Gross Margin (TTM)76.76%

Net Profit Margin (TTM)-10.87%

EPS (TTM)$-0.14

10-Day Avg Trading Volume3.18M

EPS Excl Extra (TTM)$-0.14

Revenue Growth (5Y)39.91%

EPS (Annual)$0.02

ROI (Annual)-132.31%

Gross Margin (Annual)77.77%

Net Profit Margin (5Y Avg)-37.91%

Cash / Share (Quarterly)$0.36

P/E Basic Excl Extra (TTM)142.55x

Revenue Growth QoQ (YoY)42.92%

P/E Normalized (Annual)210.05x

ROA (Last FY)0.74%

Revenue Growth TTM (YoY)30.46%

EBITD / Share (TTM)$0.08

ROE (5Y Avg)-119.17%

Operating Margin (TTM)2.31%

Cash Flow / Share (Annual)$0.04

P/B Ratio69.97x

P/B Ratio (Quarterly)88.13x

Net Income / Employee (Annual)$9,900

EV / Revenue (TTM)4.44x

Net Interest Coverage (TTM)1.03x

ROA (TTM)-6.19%

EPS Growth QoQ (YoY)-36.95%

EV / EBITDA (TTM)73.23x

EPS Incl Extra (Annual)$0.02

Current Ratio (Annual)1.70x

Quick Ratio (Quarterly)1.29x

3-Month Avg Trading Volume5.29M

52-Week Price Return-12.03%

EV / Free Cash Flow (Annual)127.73x

P/E Incl Extra (TTM)142.55x

Revenue / Employee (TTM)$664,900

Tangible BV / Share (Quarterly)$-0.95

P/S Ratio (Annual)3.53x

Asset Turnover (Annual)0.44x

52-Week High$6.51

Operating Margin (5Y Avg)-22.76%

EPS Excl Extra (Annual)$0.02

CapEx CAGR (5Y)-0.91%

26-Week Price Return-28.70%

Quick Ratio (Annual)1.41x

13-Week Price Return8.52%

Total Debt / Equity (Annual)1.64x

Current Ratio (Quarterly)1.72x

Enterprise Value$1.75B

Revenue / Share Growth (5Y)30.59%

Asset Turnover (TTM)0.57x

Revenue / Employee (Annual)$589,500

Inventory Turnover (Annual)2.45x

Pretax Margin (Annual)0.40%

Cash / Share (Annual)$0.56

3-Month Return Std Dev61.75%

Gross Margin (5Y Avg)63.74%

Net Income / Employee (TTM)$-72,300

ROE (Last FY)-349.48%

Net Interest Coverage (Annual)-0.03x

EPS Basic Excl Extra (Annual)$0.02

P/FCF (TTM)24.58x

Receivables Turnover (TTM)7.88x

EV / Free Cash Flow (TTM)140.00x

Total Debt / Equity (Quarterly)9.95x

EPS Incl Extra (TTM)$-0.14

Receivables Turnover (Annual)6.56x

ROI (TTM)-27.19%

P/S Ratio (TTM)3.13x

Pretax Margin (5Y Avg)-37.80%

Revenue / Share (Annual)$1.11

Tangible BV / Share (Annual)$-0.96

Forward P/E46.01x

Price vs S&P 500 (52W)-30.59%

P/E Ratio (TTM)142.55x

EPS Growth TTM (YoY)-78.60%

Year-to-Date Return-30.34%

5-Day Price Return-2.95%

EPS Normalized (Annual)$0.02

ROA (5Y Avg)-9.91%

Net Profit Margin (Annual)1.68%

Month-to-Date Return1.02%

Cash Flow / Share (TTM)$-0.09

EBITD / Share (Annual)$0.14

Operating Margin (Annual)11.12%

LT Debt / Equity (Annual)1.64x

P/CF (TTM)68.59x

ROI (5Y Avg)-69.25%

P/E Excl Extra (TTM)142.55x

LT Debt / Equity (Quarterly)8.47x

EPS Basic Excl Extra (TTM)$-0.14

P/B Ratio (Annual)4.03x

Inventory Turnover (TTM)2.51x

Pretax Margin (TTM)-12.15%

Book Value / Share (Annual)$4.25

Price vs S&P 500 (13W)6.56%

Beta1.09x

P/FCF (Annual)89.96x

Revenue / Share (TTM)$1.27

ROE (TTM)-297.71%

52-Week Low$2.23

vGradeD

gGradeC

mGradeC

vgmGradeC

MNKD Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 5, 2026	$0.02	-$0.01	-159.99%(-$0.03)
Q1 2026	May 6, 2026	$0.01	-$0.02	-399.85%(-$0.03)
Q4 2025	Feb 26, 2026	$0.03	$0.01	-66.67%(-$0.02)
Q3 2025	Nov 5, 2025	$0.03	$0.07	+110.02%(+$0.04)
Q2 2025	Aug 6, 2025	$0.08	$0.05	-34.79%(-$0.03)

MNKD Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.14

Industry Peers — Pharmaceuticals(570)

Symbol	Value Score	Growth Score	Momentum Score	Price
MNKDMannkind Corporation	D	C	C	$3.95
LLYEli Lilly & Co.	D	B	C	$1174.61
JNJJohnson & Johnson	D	C	B	$268.04
ABBVABBVIE INC.	D	C	B	$255.48
MRKMerck & Co., Inc.	D	C	B	$148.35
NVSNovartis AG	C	C	C	$153.81
AZNAstraZeneca PLC	C	B	C	$162.70
NVONovo-Nordisk A/S	B	C	C	$45.61
ABTAbbott Laboratories	C	C	C	$112.47
PFEPfizer Inc.	C	D	B	$27.96
VRTXVertex Pharmaceuticals Inc	D	C	B	$541.69
BMYBristol-Myers Squibb Co.	B	B	B	$66.58
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$44.82
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$50.82
REGNRegeneron Pharmaceuticals Inc	C	C	B	$794.19
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	B	$18.03
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$36.44
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	$366.73
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$60.85
ZTSZOETIS INC.	C	C	D	$77.34
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$237.10
INSMInsmed, Inc.	F	A	C	$118.54
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$34.71
UTHRUnited Therapeutics Corp	C	C	B	$515.46
GMABGenmab A/S ADS	C	C	B	$33.23
VTRSViatris Inc. Common Stock	B	C	B	$16.34
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$247.91
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$244.54
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$76.60
BMRNBioMarin Pharmaceuticals Inc	C	C	B	$64.67
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	B	$533.76
CORTCorcept Therapeutics Inc.	F	C	B	$113.88
ELANElanco Animal Health Incorporated Common Stock	C	B	C	$24.11
ARWRArrowhead Research Corporation	D	A	B	$84.91
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.73
AXSMAxsome Therapeutics, Inc	D	B	C	$199.02
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.18
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$61.05
CYTKCytokinetics Inc.	F	D	C	$72.09
ABVXAbivax SA American Depositary Shares	—	—	C	$113.35
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$344.75
PTGXProtagonist Therapeutics, Inc	F	B	B	$144.33
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.84
TGTXTG Therapeutics, Inc.	D	B	B	$53.93
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	$90.36
ALKSAlkermes Inc. plc	D	C	B	$47.41
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$107.17
ERASErasca, Inc. Common Stock	—	—	A	$18.03
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$65.67
BLTEBelite Bio, Inc American Depositary Shares	—	—	C	$151.72

About Mannkind Corporation

MannKind is a biopharmaceutical company commercializing therapies for cardiometabolic and orphan lung diseases. Its portfolio includes Afrezza, an ultra rapid-acting inhaled insulin for diabetes; Furoscix, a furosemide injection for heart failure and chronic kidney disease; and V-Go, a wearable device for continuous subcutaneous insulin infusion.